These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35501745)

  • 1. Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience.
    Fukushima A; Iessa N; Balakrishnan MR; Pal SN
    BMC Med Inform Decis Mak; 2022 May; 22(1):118. PubMed ID: 35501745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative Study.
    Kiguba R; Zakumumpa H; Ndagije HB; Mwebaza N; Ssenyonga R; Tregunno P; Harrison K; Pirmohamed M
    Drug Saf; 2023 Jun; 46(6):565-574. PubMed ID: 37097426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences on the Uptake of and Engagement With Health and Well-Being Smartphone Apps: Systematic Review.
    Szinay D; Jones A; Chadborn T; Brown J; Naughton F
    J Med Internet Res; 2020 May; 22(5):e17572. PubMed ID: 32348255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobile apps for quick adverse drug reaction report: A scoping review.
    Parracha ER; Advinha AM; Lopes MJ; Oliveira-Martins S
    Pharmacoepidemiol Drug Saf; 2023 Jan; 32(1):19-27. PubMed ID: 36125022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial.
    Defer G; Le Caignec F; Fedrizzi S; Montastruc F; Chevanne D; Parienti JJ; Peyro-Saint-Paul L
    Trials; 2018 Mar; 19(1):174. PubMed ID: 29523169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria.
    Elemuwa UG; Bitrus F; Oreagba IA; Osakwe AI; Abiodun AS; Onu K; Abubakar A; Faniyi AE; Etuk V; Yuah D; Momodu R; Adeyeye CM
    Pharmaceut Med; 2024 May; 38(3):251-259. PubMed ID: 38705932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
    Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
    Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP
    Montastruc F; Bagheri H; Lacroix I; Damase-Michel C; Chebane L; Rousseau V; Jouanjus E; Lapeyre-Mestre M; Durrieu G; Montastruc JL
    Drug Saf; 2018 May; 41(5):511-514. PubMed ID: 29270770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Smartphones and Health Apps to Change and Manage Health Behaviors: A Population-Based Survey.
    Ernsting C; Dombrowski SU; Oedekoven M; O Sullivan JL; Kanzler M; Kuhlmey A; Gellert P
    J Med Internet Res; 2017 Apr; 19(4):e101. PubMed ID: 28381394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination.
    Wilson K; Atkinson KM; Westeinde J; Bell C; Marty K; Fergusson D; Deeks SL; Crowcroft N; Bettinger JA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1738-48. PubMed ID: 26905396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
    Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
    Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is India ready for mental health apps (MHApps)? A quantitative-qualitative exploration of caregivers' perspective on smartphone-based solutions for managing severe mental illnesses in low resource settings.
    Sinha Deb K; Tuli A; Sood M; Chadda R; Verma R; Kumar S; Ganesh R; Singh P
    PLoS One; 2018; 13(9):e0203353. PubMed ID: 30231056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives and Preferences of Adult Smartphone Users Regarding Nutrition and Diet Apps: Web-Based Survey Study.
    Vasiloglou MF; Christodoulidis S; Reber E; Stathopoulou T; Lu Y; Stanga Z; Mougiakakou S
    JMIR Mhealth Uhealth; 2021 Jul; 9(7):e27885. PubMed ID: 34328425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of smartphone apps in bipolar disorder: An international web-based survey of feature preferences and privacy concerns.
    Morton E; Nicholas J; Lapadat L; O'Brien HL; Barnes SJ; Poh C; Michalak EE
    J Affect Disord; 2021 Dec; 295():1102-1109. PubMed ID: 34706421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. e-Therapies in England for stress, anxiety or depression: how are apps developed? A survey of NHS e-therapy developers.
    Bennion MR; Hardy GE; Moore RK; Kellett S; Millings A
    BMJ Health Care Inform; 2019 Jun; 26(1):. PubMed ID: 31171556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction Monitoring: Development and Usability Study.
    Di Filippo M; Avellone A; Belingheri M; Paladino ME; Riva MA; Zambon A; Pescini D
    JMIR Hum Factors; 2022 Nov; 9(4):e38701. PubMed ID: 35930561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of mobile phone applications to enhance personal safety from interpersonal violence - an overview of available smartphone applications in the United Kingdom.
    Ford K; Bellis MA; Judd N; Griffith N; Hughes K
    BMC Public Health; 2022 Jun; 22(1):1158. PubMed ID: 35681167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What are Headache Smartphone Application (App) Users Actually Looking for in Apps: A Qualitative Analysis of App Reviews to Determine a Patient Centered Approach to Headache Smartphone Apps.
    Minen MT; Gumpel T; Ali S; Sow F; Toy K
    Headache; 2020 Jul; 60(7):1392-1401. PubMed ID: 32535915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.